Response Genetics (RGDXQ)
OTHER OTC:RGDXQ
US Market
Holding RGDXQ?
Track your performance easily

Response Genetics (RGDXQ) Stock Price & Analysis

9 Followers

RGDXQ Stock Chart & Stats


Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

15.47%84.53%
Insiders
Mutual Funds
15.47% Other Institutional Investors
84.53% Public Companies and
Individual Investors

RGDXQ FAQ

What was Response Genetics’s price range in the past 12 months?
Response Genetics lowest stock price was $0.01 and its highest was $0.01 in the past 12 months.
    What is Response Genetics’s market cap?
    Currently, no data Available
    When is Response Genetics’s upcoming earnings report date?
    The company’s upcoming earnings report date is not yet available.
    How were Response Genetics’s earnings last quarter?
    Currently, no data Available
    Is Response Genetics overvalued?
    According to Wall Street analysts Response Genetics’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
      Does Response Genetics pay dividends?
      Response Genetics does not currently pay dividends.
      What is Response Genetics’s EPS estimate?
      Response Genetics’s EPS estimate for its next earnings report is not yet available.
      How many shares outstanding does Response Genetics have?
      Response Genetics has 38,795,000 shares outstanding.
        What happened to Response Genetics’s price movement after its last earnings report?
        Currently, no data Available
        Which hedge fund is a major shareholder of Response Genetics?
        Currently, no hedge funds are holding shares in RGDXQ
        ---

        Response Genetics Stock Smart Score

        Company Description

        Response Genetics

        Response Genetics, Inc. is engaged in the research and development of clinical diagnostic tests for cancer. Its platforms include analysis of single biomarkers using the polymerase chain reaction method as well as global gene interrogation using microarray methods from paraffin or frozen tissue specimens. It also provides pharmacogenomic testing services of clinical trial specimens to pharmaceutical companies. The company was founded by David A. Smith and Kathleen Danenberg on September 23, 1999 and is headquartered in Los Angeles, CA.
        ---
        Similar Stocks
        Company
        Price & Change
        Follow
        Genetic Technologies
        Fulgent Genetics
        Myriad Genetics
        Kura Oncology
        Popular Stocks
        ---
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis